Skip to content

Clinical trials

Phase 2 Recurrence trials in Belgium

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Recurrence Phase: Phase 2 Country / region: Belgium Clear all

39 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20052
20063
20073
20082
20093
20122
20132
20142
20152
20162
20173
20183
20191
20203
20214
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed30
Terminated6
Active, not recruiting3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Celgene3
Novartis Pharmaceuticals3
The Lymphoma Academic Research Organisation3
AstraZeneca2
Cliniques universitaires Saint-Luc- Université Catholique de Louvain2
GlaxoSmithKline2
ADC Therapeutics S.A.1
ARCAGY/ GINECO GROUP1
Acrotech Biopharma Inc.1
Allogene Therapeutics1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Recurrence39
Neoplasm Metastasis8
Head and Neck Neoplasms4
Lymphoma4
Leukemia3
Leukemia, Lymphocytic, Chronic, B-Cell3
Lymphoma, Large B-Cell, Diffuse3
Lymphoma, Non-Hodgkin3
Multiple Myeloma3
Ovarian Neoplasms3

Trials

Showing 1 to 25 of 39. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.